SRGN and neoplasm: Of the 53 upregulated genes reported, our analysis identified 31 as upregulated in at least one tumor type compared to non-tumor tissues (ASAP1, BICC1, C3AR1, CD14, CD53, CD86, COCH, COL6A3, CSF1R, CTSK, CTSS, CYBB, DMXL2, FAP, FBN2, FN1, GPC3, IFI44, ITGA4, KRT7, LAMA4, LAPTM5, LRRC15, MAP1B, PTH1R, RAB31, RGS1, SPP1, SRGN, TGOLN2, TLR2).